Deerfield Mgmt, L.P. 13D and 13G filings for ARS Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-03-24 7:57 pm Sale | 2025-03-20 | 13D | ARS Pharmaceuticals, Inc. SPRY | Deerfield Mgmt, L.P. | 10,514,657 10.720% | -563,270 (-5.08%) | Filing |
| 2022-11-18 5:06 pm Purchase | 2022-11-08 | 13D | ARS Pharmaceuticals, Inc. SPRY | Deerfield Mgmt, L.P. | 11,077,927 11.810% | 11,077,927 (New Position) | Filing |